19-29708260-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM5PP2
The NM_031448.6(C19orf12):c.154G>A(p.Ala52Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000869 in 1,611,610 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A52P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_031448.6 missense
Scores
Clinical Significance
Conservation
Publications
- neurodegeneration with brain iron accumulation 4Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Illumina, Ambry Genetics, G2P
- hereditary spastic paraplegia 43Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| C19orf12 | NM_031448.6 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 3 | ENST00000323670.14 | NP_113636.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| C19orf12 | ENST00000323670.14 | c.154G>A | p.Ala52Thr | missense_variant | Exon 2 of 3 | 2 | NM_031448.6 | ENSP00000313332.9 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000121 AC: 3AN: 247336 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1459480Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 726116 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74318 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 43 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1682835). This variant has not been reported in the literature in individuals affected with C19orf12-related conditions. This variant is present in population databases (rs376103979, gnomAD 0.003%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 63 of the C19orf12 protein (p.Ala63Thr). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at